HSF2BP
Basic information
Region (hg38): 21:43529186-43659488
Links
Phenotypes
GenCC
Source:
- premature ovarian failure 19 (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Premature ovarian failure 19 | AR | Obstetric | The condition can involve infertility, and fertility treatment has been described as successful in some indviduals | Obstetric | 32845237 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HSF2BP gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 16 | 19 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 2 | 17 | 3 | 0 |
Variants in HSF2BP
This is a list of pathogenic ClinVar variants found in the HSF2BP region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
21-43529816-G-A | not specified | Uncertain significance (Dec 18, 2023) | ||
21-43529824-C-T | not specified | Uncertain significance (Oct 09, 2024) | ||
21-43529848-C-T | not specified | Uncertain significance (Mar 22, 2023) | ||
21-43529903-G-C | not specified | Uncertain significance (Sep 29, 2023) | ||
21-43529903-G-T | not specified | Uncertain significance (Jul 20, 2022) | ||
21-43529960-G-C | not specified | Uncertain significance (Aug 17, 2022) | ||
21-43592280-C-T | Likely benign (Feb 01, 2024) | |||
21-43613833-T-C | not specified | Uncertain significance (Nov 24, 2024) | ||
21-43613852-C-A | Uncertain significance (Sep 01, 2024) | |||
21-43613858-T-C | not specified | Uncertain significance (Nov 21, 2024) | ||
21-43613876-GCAATATGGTGTC-G | Uncertain significance (Feb 01, 2024) | |||
21-43613890-A-C | not specified | Uncertain significance (Oct 20, 2024) | ||
21-43613900-G-A | not specified | Uncertain significance (Dec 12, 2022) | ||
21-43613913-C-G | not specified | Uncertain significance (Jun 28, 2022) | ||
21-43613923-C-T | not specified | Uncertain significance (Oct 10, 2023) | ||
21-43630339-A-G | Premature ovarian failure 19 | Likely pathogenic (Aug 01, 2021) | ||
21-43630379-G-T | not specified | Likely benign (Dec 22, 2023) | ||
21-43630396-G-A | Premature ovarian failure 19 | Uncertain significance (Apr 04, 2024) | ||
21-43630403-C-T | not specified | Uncertain significance (Aug 04, 2024) | ||
21-43630413-C-T | not specified | Uncertain significance (Nov 10, 2024) | ||
21-43630424-C-T | not specified | Uncertain significance (Jun 28, 2022) | ||
21-43630448-C-A | not specified | Uncertain significance (Nov 13, 2023) | ||
21-43630452-A-T | not specified | Uncertain significance (Jul 15, 2021) | ||
21-43633273-C-T | not specified | Uncertain significance (Jun 18, 2024) | ||
21-43633331-A-G | Premature ovarian failure 19 | Likely pathogenic (Aug 01, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HSF2BP | protein_coding | protein_coding | ENST00000291560 | 8 | 130303 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.53e-16 | 0.00121 | 125672 | 0 | 76 | 125748 | 0.000302 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.172 | 197 | 190 | 1.03 | 0.0000112 | 2178 |
Missense in Polyphen | 95 | 102.59 | 0.92603 | 1203 | ||
Synonymous | 0.274 | 71 | 74.0 | 0.960 | 0.00000440 | 644 |
Loss of Function | -1.14 | 21 | 16.1 | 1.31 | 7.38e-7 | 207 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00200 | 0.00199 |
Ashkenazi Jewish | 0.000102 | 0.0000992 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000924 | 0.0000924 |
European (Non-Finnish) | 0.000186 | 0.000185 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000329 | 0.000327 |
Other | 0.000167 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: May be involved in modulating HSF2 activation in testis (PubMed:9651507). Inhibits BNC1 transcriptional activity during spermatogenesis, probably by sequestering it in the cytoplasm (By similarity). {ECO:0000250|UniProtKB:Q9D4G2, ECO:0000269|PubMed:9651507}.;
Recessive Scores
- pRec
- 0.101
Intolerance Scores
- loftool
- 0.516
- rvis_EVS
- -0.36
- rvis_percentile_EVS
- 29.16
Haploinsufficiency Scores
- pHI
- 0.143
- hipred
- N
- hipred_score
- 0.396
- ghis
- 0.433
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.967
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hsf2bp
- Phenotype
- hematopoietic system phenotype; reproductive system phenotype; limbs/digits/tail phenotype; renal/urinary system phenotype; immune system phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- transcription by RNA polymerase II;spermatogenesis
- Cellular component
- cytosol
- Molecular function
- protein binding